Dennis M. McGrath serves as President, Chief Financial Officer and Corporate Secretary of the Company. has served as the Company’s President since March 2019 (having served as Executive Vice President from March 2017 to March 2019) and as the Company’s Chief Financial Officer since March 2017. Previously, from 2000 to 2017 Mr. McGrath served in several senior level positions of PhotoMedex, Inc. (formerly, Nasdaq: PHMD), a global manufacturer and distributor of medical device equipment and services, including from 2011 to 2017 as director, President, and Chief Financial Officer. Prior to PhotoMedex’s reverse merger with Radiancy, Inc in December 2011, he also served as Chief Executive Officer from 2009 to 2011 and served as Vice President of Finance and Chief Financial Officer from 2000 to 2009. He received honors aP.A.C.T. (Philadelphia Alliance for Capital and Technology) finalist for the 2011 Investment Deal of the Year, award winne for the SmartCEO Magazine 2012 CEO of the Year for Turnaround Company, and finalist for the Ernst & Young 2013 Entrepreneur of the Year. He has extensive experience in mergers and acquisitions, both domestically and internationally, and particularly involving public company acquisitions, including Surgical Laser Technologies, Inc, (formerly, Nasdaq: SLTI), ProCyte Corporation (formerly, Nasdaq: PRCY), LCA Vision, Inc. (formerly, Nasdaq: LCAV) and Think New Ideas, Inc. (formerly, Nasdaq: THNK). Prior to PhotoMedex, he served in several senior level positions of AnswerThink Consulting Group, Inc. (then, Nasdaq: ANSR, now, The Hackett Group, Nasdaq: HCKT), a business consulting and technology integration company, including from 1999 to 2000 as Chief Operating Officer of the Internet Practice, the largest division of AnswerThink Consulting Group, Inc., while concurrently during the merger of the companies, serving as the acting Chief Financial Officer of Think New Ideas, Inc. (then, Nasdaq: THNK, now, Nasdaq: HCKT), an interactive marketing services and business solutions company.
What is Dennis M. McGrath's net worth?
The estimated net worth of Dennis M. McGrath is at least $43,617.02 as of May 26th, 2021. Mr. McGrath owns 51,630 shares of DarioHealth stock worth more than $43,617 as of November 22nd. This net worth evaluation does not reflect any other investments that Mr. McGrath may own. Learn More about Dennis M. McGrath's net worth.
How do I contact Dennis M. McGrath?
Has Dennis M. McGrath been buying or selling shares of DarioHealth?
Dennis M. McGrath has not been actively trading shares of DarioHealth over the course of the past ninety days. Most recently, Dennis M. Mcgrath sold 45,773 shares of the business's stock in a transaction on Wednesday, May 26th. The shares were sold at an average price of $17.11, for a transaction totalling $783,176.03. Following the completion of the sale, the director now directly owns 51,630 shares of the company's stock, valued at $883,389.30. Learn More on Dennis M. McGrath's trading history.
Who are DarioHealth's active insiders?
Are insiders buying or selling shares of DarioHealth?
In the last year, DarioHealth insiders bought shares 4 times. They purchased a total of 20,000 shares worth more than $16,500.00. The most recent insider tranaction occured on September, 11th when insider Steven Charles Nelson bought 5,000 shares worth more than $4,000.00. Insiders at DarioHealth own 16.5% of the company.
Learn More about insider trades at DarioHealth. Information on this page was last updated on 9/11/2024.
